ArticleProceedings of the National Academy of Sciences of the United States of America2024

A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response.

Sandra L Leibel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.